Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Weber

Showing results (91-100 of 252) with videos related to

Pageof 26
Sort By:
Journal of Hepatology|May 5, 2015
High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013Helen Kovari, Bruno Ledergerber, Matthias Cavassini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2015
¹⁸F-FDG PET/CT for Therapy Control in Vascular Graft Infections: A First Feasibility StudyLars Husmann, Bert-Ram Sah, Alexandra Scherrer, et al.
Retrovirology|November 28, 2008
Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapyMarek Fischer, Beda Joos, Barbara Niederöst, et al.
Archives of Internal Medicine|January 13, 2010
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008Luigia Elzi, Catia Marzolini, Hansjakob Furrer, et al.
Archives of Internal Medicine|August 16, 2012
Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and OutcomesLuigia Elzi, Stefan Erb, Hansjakob Furrer, et al.
AIDS (London, England)|July 29, 2004
Is unsafe sexual behaviour increasing among HIV-infected individuals?Tracy R Glass, Jim Young, Pietro L Vernazza, et al.
BMC Infectious Diseases|December 21, 2021
Impact of an electronic alert on prescription patterns of meropenem, voriconazole and caspofunginLionel Chok, Katharina Kusejko, Nadia Eberhard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 20, 2009
Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infectionMilos Opravil, Thomas Klimkait, Severine Louvel, et al.
Journal of Virology|December 3, 2003
Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infectionAlexandra Trkola, Herbert Kuster, Christine Leemann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1Christine Schraner, Barbara Hasse, Urs Hasse, et al.
Pageof 26

Showing results (91-100 of 252) with videos related to

Sort By:
Pageof 26
Journal of Hepatology|May 5, 2015
High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013Helen Kovari, Bruno Ledergerber, Matthias Cavassini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2015
¹⁸F-FDG PET/CT for Therapy Control in Vascular Graft Infections: A First Feasibility StudyLars Husmann, Bert-Ram Sah, Alexandra Scherrer, et al.
Retrovirology|November 28, 2008
Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapyMarek Fischer, Beda Joos, Barbara Niederöst, et al.
Archives of Internal Medicine|January 13, 2010
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008Luigia Elzi, Catia Marzolini, Hansjakob Furrer, et al.
Archives of Internal Medicine|August 16, 2012
Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and OutcomesLuigia Elzi, Stefan Erb, Hansjakob Furrer, et al.
AIDS (London, England)|July 29, 2004
Is unsafe sexual behaviour increasing among HIV-infected individuals?Tracy R Glass, Jim Young, Pietro L Vernazza, et al.
BMC Infectious Diseases|December 21, 2021
Impact of an electronic alert on prescription patterns of meropenem, voriconazole and caspofunginLionel Chok, Katharina Kusejko, Nadia Eberhard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 20, 2009
Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infectionMilos Opravil, Thomas Klimkait, Severine Louvel, et al.
Journal of Virology|December 3, 2003
Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infectionAlexandra Trkola, Herbert Kuster, Christine Leemann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1Christine Schraner, Barbara Hasse, Urs Hasse, et al.
Pageof 26